EUVIMEDEUVIMED entdecken
Crossref

Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein

Mingxiao Liu, Di Zhang, Dongqiang Wang, Xiaodong Wu, Ying Zhang, Jigang Yin, Guan Zhu iD

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiad243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Mingxiao Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Educa…. Hauptthemen laut MEDLINE: Cryptosporidiosis, Antiprotozoal Agents, Cryptosporidium, Cryptosporidium parvum. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cryptosporidiosis is a significant diarrheal disease in humans and animals. Immunodeficient mice are the primary small animal models, but their high costs and specialized breeding/housing requirements limit in vivo drug testing. Numerous anticryptosporidial lead compounds identified in vitro remain untested in vivo.

Methods

Cryptosporidium tyzzeri, a natural mouse parasite closely related to Cryptosporidium parvum and Cryptosporidium hominis, was isolated to establish an infection model in immunocompetent mice. The model was validated using classic anticryptosporidial drugs (paromomycin and nitazoxanide) and then employed to assess the efficacy of 3 new leads (vorinostat, docetaxel, and baicalein). An in vitro culture of C. tyzzeri was also developed to complement the animal model.

Results

Chronic C. tyzzeri infection was established in chemically immunosuppressed wild-type mice. Paromomycin (1000 mg/kg/d) and nitazoxanide (100 mg/kg/d) demonstrated efficacy against C. tyzzeri. Vorinostat (30 mg/kg/d), docetaxel (25 mg/kg/d), and baicalein (50 mg/kg/d) were highly effective against C. tyzzeri infection. In vitro, nitazoxanide, vorinostat, docetaxel, and baicalein exhibited low to submicromolar efficacy against C. tyzzeri.

Conclusions

Novel in vivo and in vitro models have been developed for cost-effective anticryptosporidial drug testing. Vorinostat, docetaxel, and baicalein show potential for repurposing and/or optimization for developing new anticryptosporidial drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryptosporidiosisAntiprotozoal AgentsCryptosporidiumCryptosporidium parvumAnimalsMiceHumansParomomycinVorinostatDocetaxelCost-Benefit AnalysisPlant BreedingNitro CompoundsThiazolesFlavanones

Stichwörter der Autor:innen

Cryptosporidium tyzzeriMC-38 cellsanticryptosporidial drug discoverycryptosporidiosisimmunocompetent mouse modelin vitro culture

Substanzen

ParomomycinVorinostatAntiprotozoal AgentsDocetaxelnitazoxanideNitro CompoundsThiazolesbaicaleinFlavanones

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin…

ORCID-Profile: Guan Zhu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Liu, M., Zhang, D., Wang, D., Wu, X., Zhang, Y., Yin, J., & Zhu, G. (2023). Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad243

Vancouver

Liu M, Zhang D, Wang D, Wu X, Zhang Y, Yin J, et al. Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad243

BibTeX
@article{Liu2023,
  author = {Liu, Mingxiao and Zhang, Di and Wang, Dongqiang and Wu, Xiaodong and Zhang, Ying and Yin, Jigang and Zhu, Guan},
  title = {Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiad243}
}
Kostenlos starten →